BGM

BGM Group Ltd. - Class A Ordinary Shares (BGM)

About BGM Group Ltd. - Class A Ordinary Shares (BGM)

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. It operates through the following segments: Oxytetracycline and Licorice Products, and Traditional Chinese Medicine Derivatives (TCMD); Heparin Products and Sausage Casing; and Fertilizer. The Oxytetracycline and Licorice Products, and TCMD segment focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, and TCMD. The Heparin Products and Sausage Casing segment treats cardiovascular diseases, cerebrovascular diseases, and hemodialysis. The Fertilizer segment includes Xiongguan, Organic Fertilizer and Xiongguan, and Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.

Details

Daily high
$0.27
Daily low
$0.25
Price at open
$0.25
52 Week High
$11.79
52 Week Low
$0.23
Market cap
105.6M
Dividend yield
-
Volume
58,487
Avg. volume
116,272
P/E ratio
-1.57

BGM Group Ltd. - Class A Ordinary Shares News

Details

Daily high
$0.27
Daily low
$0.25
Price at open
$0.25
52 Week High
$11.79
52 Week Low
$0.23
Market cap
105.6M
Dividend yield
-
Volume
58,487
Avg. volume
116,272
P/E ratio
-1.57